Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Smoking × Celecoxib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 22 Breast Neoplasms 19 Carcinoma, Non-Small-Cell Lung 17 Lung Neoplasms 14 Head and Neck Neoplasms 10 Rectal Neoplasms 9 Colonic Neoplasms 9 Prostatic Neoplasms 8 Pancreatic Neoplasms 6 Mouth Neoplasms 6 Glioblastoma 6 Neoplasm Metastasis 5 Esophageal Neoplasms 5 Central Nervous System Neoplasms 5 Unspecified Adult Solid Tumor, Protocol Specific 4 Triple Negative Breast Neoplasms 4 Recurrence 4 Precancerous Conditions 4 Ovarian Neoplasms 4 Neuroblastoma 4 Gliosarcoma 4 Carcinoma 4 Adenomatous Polyposis Coli 4 Sarcoma 3 Oropharyngeal Neoplasms 3 Neoplasms 3 Laryngeal Neoplasms 3 Hypopharyngeal Neoplasms 3 Glioma 3 Carcinoma, Hepatocellular 3

Interventions

Tobacco Use Cessation Devices 5 Standard of Care 3 Varenicline 2 Tomography, X-Ray Computed 2 Tobacco Products 2 Surveys and Questionnaires 2 Motivational Interviewing 2 Exercise 2 olaparib 1 Yoga 1 Videotape Recording 1 Transcranial Direct Current Stimulation 1 Tablets 1 Smoking Devices 1 Restraint, Physical 1 Radon 1 Radiotherapy 1 Psychiatric Rehabilitation 1 Practice Guidelines as Topic 1 Phlebotomy 1 Patient Navigation 1 Nicotine Replacement Therapy 1 Nicotine 1 Mindfulness-Based Stress Reduction 1 Mindfulness 1 Methods 1 Liquid Biopsy 1 Interviews as Topic 1 Health 1 Focus Groups 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00981201 2012-08-01

Celecoxib as a Chemopreventive Agent in Current and Former Smokers

M.D. Anderson Cancer Center

Phase 3 Completed

Smoking

Data powered by HemOnc (CC BY 4.0) Colophon ⚡